Skip to main content
Top
Published in: Journal of Gastroenterology 10/2013

01-10-2013 | Original Article—Liver, Pancreas, and Biliary Tract

Indocyanine green fluorescent imaging for detecting extrahepatic metastasis of hepatocellular carcinoma

Authors: Shouichi Satou, Takeaki Ishizawa, Koichi Masuda, Junichi Kaneko, Taku Aoki, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Yasuhiko Sugawara, Norihiro Kokudo

Published in: Journal of Gastroenterology | Issue 10/2013

Login to get access

Abstract

Background

Indocyanine green (ICG) fluorescent imaging has been used effectively to identify hepatocellular carcinoma (HCC) in intraoperative setting. However, whether extrahepatic metastatic lesions from HCC can also be detected by this imaging is unknown.

Methods

This study was conducted on 17 patients with suspected extrahepatic HCC metastases in the lung (n = 3), adrenal gland (n = 1), lymph node (n = 7), peritoneum (n = 5) and both lymph node and peritoneum (n = 1). ICG was administered intravenously at a dose of 0.5 mg/kg prior to operation for liver function evaluation. Intraoperative ICG fluorescent imaging was performed with a near-infrared light camera system. The surgical specimens were also examined in all cases for the presence of ICG fluorescence.

Results

Of 28 lesions for which ICG fluorescence was examined intraoperatively, 24 lesions exhibited fluorescence and were proved to be HCC metastases pathologically. Five of them were newly identified by ICG fluorescent imaging. The other four lesions included two HCC metastases and two benign tumors. Of 33 suspicious metastatic lesions extirpated, 26 lesions emitting fluorescence from the specimen were all metastatic HCC. The other 7 lesions consisted of 6 benign tumors and one HCC metastasis. Accordingly, the positive predictive value of in vivo and ex vivo ICG fluorescent imaging were both 100 %, while the negative predictive value of those methods were 50 and 86 %, respectively.

Conclusions

Extrahepatic metastases from HCC exhibited ICG fluorescence when illuminated by near-infrared light, indicating their capability to transport ICG. This imaging can be a useful tool for intraoperative detection of metastasis in HCC patients.
Literature
1.
go back to reference Nimura H, Narimiya N, Mitsumori N, Yamazaki Y, Yanaga K, Urashima M. Infrared ray electronic endoscopy combined with indocyanine green injection for detection of sentinel nodes of patients with gastric cancer. Br J Surg. 2004;91:575–9.PubMedCrossRef Nimura H, Narimiya N, Mitsumori N, Yamazaki Y, Yanaga K, Urashima M. Infrared ray electronic endoscopy combined with indocyanine green injection for detection of sentinel nodes of patients with gastric cancer. Br J Surg. 2004;91:575–9.PubMedCrossRef
2.
go back to reference Ito N, Fukuta M, Tokushima T, Nakai K, Ohgi S. Sentinel node navigation surgery using indocyanine green in patients with lung cancer. Surg Today. 2004;34:581–5.PubMed Ito N, Fukuta M, Tokushima T, Nakai K, Ohgi S. Sentinel node navigation surgery using indocyanine green in patients with lung cancer. Surg Today. 2004;34:581–5.PubMed
3.
go back to reference Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005;12:211–5.PubMedCrossRef Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005;12:211–5.PubMedCrossRef
4.
go back to reference Ishizawa T, Fukushima N, Shibahara J, Masuda K, Tamura S, Aoki T, et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer. 2009;115:2491–504.PubMedCrossRef Ishizawa T, Fukushima N, Shibahara J, Masuda K, Tamura S, Aoki T, et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer. 2009;115:2491–504.PubMedCrossRef
5.
go back to reference Gotoh K, Yamada T, Ishikawa O, Takahashi H, Eguchi H, Yano M, et al. How I do it a novel image-guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation. J Surg Oncol. 2009;100:75–9.PubMedCrossRef Gotoh K, Yamada T, Ishikawa O, Takahashi H, Eguchi H, Yano M, et al. How I do it a novel image-guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation. J Surg Oncol. 2009;100:75–9.PubMedCrossRef
6.
go back to reference Une Y, Misawa K, Shimamura T, Ogasawara K, Masuko Y, Sato N, et al. Treatment of lymph node recurrence in patients with hepatocellular carcinoma. Surg Today. 1994;24:606–9.PubMedCrossRef Une Y, Misawa K, Shimamura T, Ogasawara K, Masuko Y, Sato N, et al. Treatment of lymph node recurrence in patients with hepatocellular carcinoma. Surg Today. 1994;24:606–9.PubMedCrossRef
7.
go back to reference Togo S, Takahashi T, Tanaka K, Endo I, Sekido H, Shimada H. Long-term survival in a patient with hepatocellular carcinoma with resection of a metastatic lymph node after percutaneous ethanol injection therapy. Int J Clin Oncol. 2004;9:393–7.PubMedCrossRef Togo S, Takahashi T, Tanaka K, Endo I, Sekido H, Shimada H. Long-term survival in a patient with hepatocellular carcinoma with resection of a metastatic lymph node after percutaneous ethanol injection therapy. Int J Clin Oncol. 2004;9:393–7.PubMedCrossRef
8.
go back to reference Lin C, Liang H, Lee H, Huang G, Yang P, Ho M, et al. Clinical manifestations and survival of hepatocellular carcinoma patients with peritoneal metastasis. J Gastroenterol Hepatol. 2009;24:815–20.PubMedCrossRef Lin C, Liang H, Lee H, Huang G, Yang P, Ho M, et al. Clinical manifestations and survival of hepatocellular carcinoma patients with peritoneal metastasis. J Gastroenterol Hepatol. 2009;24:815–20.PubMedCrossRef
9.
go back to reference Tomimaru Y, Sasaki Y, Yamada T, Eguchi H, Takami K, Ohigashi H, et al. The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma. Am J Surg. 2006;192:46–51.PubMedCrossRef Tomimaru Y, Sasaki Y, Yamada T, Eguchi H, Takami K, Ohigashi H, et al. The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma. Am J Surg. 2006;192:46–51.PubMedCrossRef
10.
go back to reference Chen F, Sato K, Fujinaga T, Sonobe M, Shoji T, Sakai H, et al. Pulmonary resection for metastases from hepatocellular carcinoma. World J Surg. 2008;32:2213–7.PubMedCrossRef Chen F, Sato K, Fujinaga T, Sonobe M, Shoji T, Sakai H, et al. Pulmonary resection for metastases from hepatocellular carcinoma. World J Surg. 2008;32:2213–7.PubMedCrossRef
11.
go back to reference Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. New Engl J Med. 2008;359:378–90.PubMedCrossRef Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. New Engl J Med. 2008;359:378–90.PubMedCrossRef
13.
go back to reference Ishizawa T, Bandai Y, Kokudo N. Fluorescent cholangiography using indocyanine green for laparoscopic cholecystectomy: an initial experience. Arch Surg. 2009;144:381–2.PubMedCrossRef Ishizawa T, Bandai Y, Kokudo N. Fluorescent cholangiography using indocyanine green for laparoscopic cholecystectomy: an initial experience. Arch Surg. 2009;144:381–2.PubMedCrossRef
Metadata
Title
Indocyanine green fluorescent imaging for detecting extrahepatic metastasis of hepatocellular carcinoma
Authors
Shouichi Satou
Takeaki Ishizawa
Koichi Masuda
Junichi Kaneko
Taku Aoki
Yoshihiro Sakamoto
Kiyoshi Hasegawa
Yasuhiko Sugawara
Norihiro Kokudo
Publication date
01-10-2013
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 10/2013
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-012-0709-6

Other articles of this Issue 10/2013

Journal of Gastroenterology 10/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.